ROBERT J. SHOVLIN Insider Trading $NEO NEOGENOMICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT J. SHOVLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT J. SHOVLIN. ROBERT J. SHOVLIN is Chief Growth Officer in NEOGENOMICS INC ($NEO) and Chief Operating Officer in NEOGENOMICS INC ($NEO) and President, Clinical Services in NEOGENOMICS INC ($NEO).
ROBERT J. SHOVLIN in NEOGENOMICS INC
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of ROBERT J. SHOVLIN: President, Clinical Services, Chief Growth Officer, Chief Operating Officer
Holdings: 147,528 shares
Current Value: $1,186,125
Latest Transaction: Mar 03 2021
$NEO Market Capitalization: $625.74M
$NEO Previous Close: $8.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT J. SHOVLIN in NEOGENOMICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 53.17 | 38,688 | 2,057,041 | 38,688 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 6,827 | 0 | 153,747 | 146.9 K to 153.7 K (+4.65 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 608 | 0 | 146,920 | 147.5 K to 146.9 K (-0.41 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 742 | 0 | 147,528 | 148.3 K to 147.5 K (-0.50 %) |
| Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 19.60 | 16,724 | 327,790 | 50,173 | |
| Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.52 | 66,667 | 501,336 | 0 | |
| Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 38.17 | 81,356 | 3,105,359 | 148,270 | 229.6 K to 148.3 K (-35.43 %) |
| Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 19.60 | 16,724 | 327,790 | 229,626 | 212.9 K to 229.6 K (+7.86 %) |
| Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.52 | 66,667 | 501,336 | 212,902 | 146.2 K to 212.9 K (+45.59 %) |
| May 27 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 5,405 | 0 | 146,235 | 151.6 K to 146.2 K (-3.56 %) |
| Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 8.03 | 96,167 | 772,221 | 96,167 | |
| Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 30.86 | 98,093 | 3,027,150 | 151,640 | 249.7 K to 151.6 K (-39.28 %) |
| Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 8.03 | 96,167 | 772,221 | 249,733 | 153.6 K to 249.7 K (+62.62 %) |
| Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 28.33 | 56,271 | 1,594,157 | 56,271 | |
| Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 8,736 | 0 | 153,566 | 144.8 K to 153.6 K (+6.03 %) |
| Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 810 | 0 | 144,830 | 145.6 K to 144.8 K (-0.56 %) |
| Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 8.03 | 96,166 | 772,213 | 192,334 | |
| Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 22.74 | 35,801 | 814,115 | 145,640 | 181.4 K to 145.6 K (-19.73 %) |
| Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 23.11 | 70,473 | 1,628,631 | 181,441 | 251.9 K to 181.4 K (-27.98 %) |
| Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 8.03 | 96,166 | 772,213 | 251,914 | 155.7 K to 251.9 K (+61.74 %) |
| May 29 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 6,559 | 0 | 155,748 | 162.3 K to 155.7 K (-4.04 %) |
| May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.52 | 66,667 | 501,336 | 66,667 | |
| May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.15 | 66,666 | 476,662 | 0 | |
| May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 22.14 | 66,667 | 1,476,007 | 162,307 | 229 K to 162.3 K (-29.12 %) |
| May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 22.14 | 52,680 | 1,166,335 | 228,974 | 281.7 K to 229 K (-18.70 %) |
| May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.52 | 66,667 | 501,336 | 281,654 | 215 K to 281.7 K (+31.01 %) |
| May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.15 | 66,666 | 476,662 | 214,987 | 148.3 K to 215 K (+44.95 %) |
| Mar 05 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 19.60 | 66,897 | 1,311,181 | 66,897 | |
| Mar 05 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 10,944 | 0 | 148,321 | 137.4 K to 148.3 K (+7.97 %) |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.52 | 66,666 | 501,328 | 133,334 | |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.15 | 13,986 | 100,000 | 66,666 | |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.15 | 119,348 | 853,338 | 80,652 | |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.15 | 13,986 | 100,000 | 137,377 | 123.4 K to 137.4 K (+11.33 %) |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 19.23 | 44,135 | 848,716 | 123,391 | 167.5 K to 123.4 K (-26.35 %) |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 18.88 | 141,879 | 2,678,676 | 167,526 | 309.4 K to 167.5 K (-45.86 %) |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.52 | 66,666 | 501,328 | 309,405 | 242.7 K to 309.4 K (+27.46 %) |
| Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.15 | 119,348 | 853,338 | 242,739 | 123.4 K to 242.7 K (+96.72 %) |
| Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 4.79 | 300,000 | 1,437,000 | 0 | |
| Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 16.76 | 36,493 | 611,623 | 123,391 | 159.9 K to 123.4 K (-22.82 %) |
| Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 17.05 | 180,000 | 3,069,000 | 159,884 | 339.9 K to 159.9 K (-52.96 %) |
| Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 4.79 | 300,000 | 1,437,000 | 339,884 | 39.9 K to 339.9 K (+752.18 %) |
| Jun 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 13.12 | 12,941 | 169,786 | 39,884 | 52.8 K to 39.9 K (-24.50 %) |
| May 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 0.00 | 16,666 | 0 | 33,334 | |
| May 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 11.57 | 3,725 | 43,098 | 19,491 | 23.2 K to 19.5 K (-16.04 %) |
| May 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 0.00 | 16,666 | 0 | 23,216 | 6.6 K to 23.2 K (+254.44 %) |
| Feb 28 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 8.03 | 288,500 | 2,316,655 | 288,500 | |
| May 30 2017 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| May 02 2017 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 7.52 | 200,000 | 1,504,000 | 200,000 | |
| May 03 2016 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | Chief Growth Office ... | Option Exercise | A | 7.15 | 200,000 | 1,430,000 | 200,000 | |
| Dec 04 2015 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | Chief Operating Off ... | Buy | P | 7.75 | 6,550 | 50,763 | 6,550 | 0 to 6.6 K |
| Oct 14 2014 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | Chief Operating Off ... | Option Exercise | A | 4.79 | 300,000 | 1,437,000 | 300,000 |
Page: 1